Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 32.43
0.123 %
$ 1.82 B
Market Cap
24.57
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Supernus Pharmaceuticals, Inc.
| Revenue | 662 M |
| Cost Of Revenue | 77.9 M |
| Gross Profit | 584 M |
| Operating Expenses | 502 M |
| Operating Income | 81.7 M |
| Other Expenses | 7.8 M |
| Net Income | 73.9 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||
| Revenue | 661.8 | 607.5 | 667.2 | 579.8 | 520.4 | 392.8 | 408.9 | 302.2 | 215.0 | 144.4 | 122.0 | 12.0 | 1.5 | 0.8 | 0.1 | 37.9 | 8.9 | 4.2 |
| GROSS PROFIT | ||||||||||||||||||
| Cost Of Revenue | 77.9 | 83.8 | 87.2 | 75.1 | 52.5 | 16.7 | 15.4 | 15.2 | 12.0 | 8.4 | 5.8 | 1.1 | 0 | 0 | (13.4) | (8.6) | 336 | 0 |
| Gross Profit | 583.9 | 523.7 | 580.0 | 504.7 | 467.9 | 376.1 | 393.5 | 287.0 | 203.0 | 136.0 | 116.3 | 10.9 | 1.5 | 0.8 | 13.5 | 46.5 | 8.9 | 4.2 |
| OPERATING INCOME | ||||||||||||||||||
| Operating Expenses | 502.2 | 529.0 | 534.4 | 425.2 | 292.3 | 227.5 | 249.1 | 187.5 | 148.8 | 118.3 | 92.1 | 72.8 | 43.6 | 38.6 | 40.2 | 33.9 | 34.8 | 23.3 |
| Selling, General and Administrative Expenses | 321.6 | 336.4 | 377.2 | 304.8 | 200.7 | 158.4 | 159.9 | 137.9 | 106.0 | 89.2 | 72.5 | 55.6 | 20.1 | 7.9 | 5.1 | 4.6 | 4.3 | 4.0 |
| Research and Development Expenses | 108.8 | 91.6 | 74.6 | 90.5 | 76.0 | 69.1 | 89.2 | 49.6 | 42.8 | 29.1 | 19.6 | 17.2 | 23.5 | 30.6 | 35.1 | 29.3 | 30.5 | 19.3 |
| Operating Income | 81.7 | (5.3) | 67.3 | 86.0 | 173.7 | 148.6 | 144.4 | 99.5 | 54.2 | 17.7 | 24.2 | (61.9) | (42.2) | (37.8) | (40.1) | 4.0 | (25.9) | (19.0) |
| PRE-TAX INCOME | ||||||||||||||||||
| Interest Income Expense | 0 | 2.4 | 7.1 | 23.4 | 23.8 | 22.7 | 18.1 | 1.6 | 5.1 | 1.2 | 5.0 | 7.8 | 3.6 | 1.9 | 0.1 | 0.1 | 8.7 | 1.8 |
| Total Other Income | 16.2 | 8.0 | 14.6 | (12.9) | (5.0) | (1.1) | (4.3) | 1.1 | (3.8) | (6.2) | (4.4) | (30.4) | (4.1) | (1.7) | 0.6 | 0.1 | (7.6) | 1.8 |
| Pre-Tax Income | 97.9 | 2.8 | 60.7 | 73.2 | 168.6 | 147.5 | 140.2 | 100.6 | 50.4 | 15.0 | 19.9 | (92.3) | (46.3) | (39.5) | (39.5) | 4.1 | (33.5) | (17.3) |
| NET INCOME | ||||||||||||||||||
| Tax Provision | 24.0 | 1.5 | 32 K | 19.8 | 41.7 | 34.4 | 29.2 | 43.3 | (40.9) | 1.0 | 4.0 | 7.1 | 1.1 | (16.2) | (0.4) | 3.8 | 1.1 | 1.8 |
| Net Income | 73.9 | 1.3 | 60.7 | 53.4 | 127.0 | 113.1 | 111.0 | 57.3 | 91.2 | 14.0 | 19.9 | (92.3) | (46.3) | 56.0 | (38.5) | 0.5 | (33.5) | (17.3) |
| EPS | 1.34 | 0.0241 | 1.13 | 1.01 | 2.41 | 2.16 | 2.13 | 1.13 | 1.84 | 0.29 | 0.47 | 2.9 | 2.65 | 3.64 | 2.78 | 0.21 | 2.42 | 1.25 |